ArticleFrontiers in pharmacology2021
Polyphenols and Pharmacological Screening of a
Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Trial
- Biological Characterization and Essential Oil Profiles of Eastern European Cultivars ofMolecules (Basel, Switzerland) · 2026Article
- Influence of Plant Phenology on Chemical Composition of Monarda fistulosa L. Organs and their Bioactive Properties.Plant foods for human nutrition (Dordrecht, Netherlands) · 2024Article
- Article
- Eucalypt Extracts Prepared by a No-Waste Method and Their 3D-Printed Dosage Forms Show Antimicrobial and Anti-Inflammatory Activity.Plants (Basel, Switzerland) · 2024Article
- Spectrophotometric and Chromatographic Assessment of Total Polyphenol and Flavonoid Content inMolecules (Basel, Switzerland) · 2024Article
- Phytochemical, Technological, and Pharmacological Study on the Galenic Dry Extracts Prepared from German Chamomile (Plants (Basel, Switzerland) · 2024Article
- Pharmacognostic Evaluation ofPlants (Basel, Switzerland) · 2023Article
- Sage, Rosemary, and Bay Laurel Hydrodistillation By-Products as a Source of Bioactive Compounds.Plants (Basel, Switzerland) · 2023Article
- American Cranberry (Plants (Basel, Switzerland) · 2023Article
- Comparative HPLC-DAD-ESI-QTOF/MS/MS Analysis of Bioactive Phenolic Compounds Content in the Methanolic Extracts from Flowering Herbs ofPharmaceutics · 2023Article
- Post-Distillation By-Products of Aromatic Plants from Lamiaceae Family as Rich Sources of Antioxidants and Enzyme Inhibitors.Antioxidants (Basel, Switzerland) · 2023Article
- Green Extraction of Polyphenols from Waste Bentonite to Produce Functional Antioxidant Excipients for Cosmetic and Pharmaceutical Purposes: A Waste-to-Market Approach.Antioxidants (Basel, Switzerland) · 2022Article
- Polyphenols in Metabolic Diseases.Molecules (Basel, Switzerland) · 2022Review
- Pharmacological Potential and Chemical Composition ofMolecules (Basel, Switzerland) · 2021Article
- Phytochemical and Pharmacological Evaluation of the Residue By-Product Developed from theFoods (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to determine the composition and content of polyphenols in the dry extract obtained from the hydrodistilled residue by-product of the wild bergamot (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.